期刊文献+

胰腺癌淋巴结中血管内皮生长因子-C及其受体-3蛋白表达及其临床意义 被引量:2

Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 protein in nymph nodes of pancreatic cancer and its clinical significance
下载PDF
导出
摘要 目的通过胰腺癌标本组织和淋巴结中血管内皮生长因子(VEGF)-C及其受体(VEGFR 3)蛋白的检测,探讨VEGF-C及VEGFR-3蛋白表达与胰腺癌淋巴结转移的相关性。方法采用免疫组织化学方法检测胰腺癌组织标本及其淋巴结中VEGF-C及VEGFR-3蛋白的表达,分析VEGF-C及VEGFR-3蛋白表达与胰腺癌的临床病理特征和淋巴结转移的相关性。结果胰腺癌组织标本中VEGF-C、VEGFR-3蛋白表达的阳性率分别为80%(20/25)、92%(23/25)。一般情况下,VEGF-C、VEGFR-3蛋白在胰腺癌组织周边的表达强于癌灶中央。VEGF-C、VEGFR-3蛋白在常规病理学检测(苏木精-伊红染色)阳性的淋巴结内的表达明显强于阴性淋巴结中(P值均<0.05)。不同分化程度(x^2=4.17,P=0.041)、有无十二指肠侵犯(x^2=5.77,P=0.018)的胰腺癌标本中VEGF-C表达的差异均有统计学意义;不同分化程度(x^2=1.45,P=0.221)、有无十二指肠侵犯(x^2=2.01,P=0.167)的胰腺癌标本中VEGFR-3蛋白表达的差异均无统计学意义。结论 VEGF C和VEGFR-3蛋白的表达与胰腺癌淋巴结转移密切相关,推测其与诱导胰腺癌淋巴管生成,促进肿瘤细胞淋巴道转移有关。 Objective To observe the expression of vascular endothelial growth factor-C(VEGF-C) and vascular endothelial growth factor receptor-3 protein(VEGFR-3) in pancreatic cancer tissues and lymph nodes,so as to discuss the relationship between VEGF-C and VEGFR-3 with the lymphatic metastasis of pancreatic cancer. Methods The expression of VEGF-C and VEGFR-3 protein in pancreatic cancer tissues and lymph nodes was detected immunohistochemically in 25 patients who had undergone pancreaticoduodenectomy with extended lymphadenectomy.The relation between the expression of VEGF-C and VEGFR-3 protein and lymphatic metastasis of pancreatic cancer was also analyzed.Results The positive rates of VEGF-C and VEGFR-3 in pancreatic cancer specimens were 80%(20/25),92%(23/25),respectively.The expression of VEGF-C and VEGFR-3 at the border of the tumor specimen was significantly higher than that at the center of the tumor;VEGF-C and VEGFR- 3 protein expression was stronger in patients with a positive result in HE staining compared with those with negative results(P0.05).The expression of VEGF-C was significantly different between patients with different differentiation degree(x^2=4.17,P = 0.041) and the presence of duodenal infiltration(x^2=5.77,P = 0.018). The expression of VEGFR-3 was not significantly different in patients with different differential diagnoses. Conclusion The expression of VEGF-C and VEGFR-3 protein is closely related to the incidence of lymph node metastasis of the pancreatic head carcinoma.VEGF-C and VEGFR-3 may induce lymphangiogenisis in pancreatic cancer,and thus promote the tumor cell lymph metastasis.
出处 《上海医学》 CAS CSCD 北大核心 2010年第11期1016-1019,共4页 Shanghai Medical Journal
基金 2007-2009年卫生部临床重点学科项目 2008上海市优秀学科带头人计划(编号08XD14010)
关键词 胰腺癌 淋巴结转移 临床病理特点 血管内皮生长因子-C 血管内皮生长因子受体-3 Pancreatic carcinoma Lymph node metastasis Clinico-pathological Characteristics Vascular endothelial growth factor-C Vascular endothelial growth factor receptor-3
  • 相关文献

参考文献11

  • 1Podgrabinska S,Braun P,Velasco P,et al.Molecular characterization of lymphatic endoihelial cells.Proc Natl Acad Sci U S A,2002,99:16069-16074.
  • 2Mattila M M,Ruohola J K,Karpanen T,et al.VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.Int J Cancer,2002,98:946-951.
  • 3Van Trappen P O,Pepper M S.Lymphatic dissemination of tumour cells and the formation of micromctastases.Lancet Oncol,2002,3:44-52.
  • 4Makinen T,Veikkola T,Mustjoki S,et al.Isolated lymphatic endothelial cells transduce growth,survival and migratory signals via the VEGF-C/D receptor VEGFR-3.EMBO J,2001,20:4762-4773.
  • 5Kurahara H.Takao S,Maemura K,et al.Impact of vascular endothelial growth factor-C and-D expression in human pancreatic cancer:its relationship to lymph node metastasis.Clin Cancer Res,2004,10:8413-8420.
  • 6Ochi N,Matsuo Y,Sawai H,et al.Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.Pancreas,2007,34:444-451.
  • 7Schneider M,Büchler P,Giese N,et al.Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.Int J Oncol,2006,28:883-890.
  • 8李凯,陶京,杨智勇,许州,王春友.胰腺癌原位种植瘤中VEGF-C的器官差异表达和作用[J].中国组织化学与细胞化学杂志,2007,16(2):175-179. 被引量:3
  • 9Dadras S S,Paul T,Bertoncini J,et al.Tumor lymphangiogenesis:a novel prognostic indicator for cutaneous melanoma metastasis and survival.Am J Pathol,2003,162:1951-1960.
  • 10刘进,薛新波.P53、VEGF和VEGF-C在胰腺癌中的表达及意义[J].华中科技大学学报(医学版),2004,33(4):472-474. 被引量:7

二级参考文献19

  • 1李凯,陶京,王春友.胰腺癌淋巴管生成与血管内皮生长因子C的关系[J].中华实验外科杂志,2006,23(1):16-17. 被引量:18
  • 2Holash J, Maisonpierre P C, Compton D R et al. Vessel cooption, regression, and growth in tumors medisted by angiopoietins and VEGF. Science, 1999, 284:1994
  • 3Kieser A, Weich H A, Brandner G et al. Mutant p53potentiates proteinkinase C induction of vascular endothelial growth factor expression. Oncogene, 1994, 9:963
  • 4Kang S M, Maeda K , Onoda N et al. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer, 1997,74: 502
  • 5Uchida S, Shimada Y, Watanabe G et al. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. BJC, 1998, 77: 1704
  • 6Tang R F, Itakura J, Aikawa T et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas, 2001, 22:285
  • 7Masood R, Cai J, Zheng T et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA, 1997, 94:979
  • 8Fujioka S, Yoshida K, Yanagisawa S et al. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapsefree survival. Cancer, 2001, 92:1788
  • 9Berger AC,Watson JC,Rose EA,et al.The meastatic/examined lymph node ratio is an important progonostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.Am Surg,2004,70:235-240
  • 10Joukov V,Kalkkinen N,Alitalo K,et al.A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.EMBO J,1996,15:290-298

共引文献8

同被引文献20

  • 1盖宝东,高福智,李晓娜,房学东,郑泽霖.胰腺癌p16、Bcl-2、Bax和VEGF基因表达及新生血管密度计数的意义[J].吉林大学学报(医学版),2005,31(1):94-96. 被引量:6
  • 2骆晓鸿,钟必强,李再平.CA19-9、CA125和CEA检测在胰腺癌诊断中的应用[J].贵阳医学院学报,2006,31(1):76-76. 被引量:1
  • 3李兆申.胰腺癌研究进展[J].中国实用内科杂志:临床前沿版,2006,26(12):1921-1923. 被引量:6
  • 4Bertsch T, Aschenneller C, Bewarder N, et al. European proficiency study with control serum for the tumor marker CA19-9 measured on different test systems[ J]. Clin Lab ,2013,59 ( 1 - 2 ) : 185 - 192.
  • 5Jamieson NB, Carter CR, McKay CJ, et al. Tissue biumarkers for prognosis in pancreatic ductal adenocarcinoma:a systematic review and meta-analysis [ J ]. Clin Cancer Res, 2011,17 ( 10 ) :3316 - 3331.
  • 6Zhou G, Niu L, Chiu D, et al. Changes in the expression of serum markers CA242, CA19-9, CA125, CEA, TNF x03b1, and TSGF af-ter cryosurgery in pancreatic cancer patients [ J ]. Biotechnol Lett, 2012,34 (7) : 1235 - 1241.
  • 7Marten A,Buehler MW,Werft W,et al. Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology [ J ]. Immunother, 2010,33 ( 2 ) : 219 - 224.
  • 8Gunkel, L; Mylonas I, Richter DU, et al. Immunohistochemical studies of mucinous mammary carcinomas and their metastases [ J ]. Anticancer Res ,2005,25 (3A) : 1755 - 1759.
  • 9Falzarano R, Viggiani V, Michienzi S, et al. CLEIA CA125 evi- dences : good analytical performance avoiding "Hook effect" [ J ]. Tumour Biol,2013,34( 1 ) :387 -393.
  • 10Yang XQ, Chen C, Peng CW, et al. Carbohydrate antigen 242 high- ly consists with carbohydrate antigen 19-9 in diagnosis and progno- sis of eolorectal cancer:study on 185 cases[ J]. Med Oncol,2012, 29(2) :1030 - 1036.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部